Finance

Beta
Lists
PACS:NYSE
PACS Group Inc
$35.07
-5.24%
(-1.94) 1D
$35.60
+1.51% (+0.53)
After hours
Closed: Jun 8, 4:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PACS...
Open
$37.29
High
$37.92
Low
$34.78
Mkt. cap
5.55B
Avg. vol.
875.39K
Volume
0.00
P/E ratio
23.30
52-wk high
$43.08
52-wk low
$7.50
EPS
$1.51
Shares outstanding
158.27M
No. of employees
47K
Open
$37.29
High
$37.92
Low
$34.78
Mkt. cap
5.55B
Avg. vol.
875.39K
Volume
0.00
P/E ratio
23.30
52-wk high
$43.08
52-wk low
$7.50
EPS
$1.51
Shares outstanding
158.27M
No. of employees
47K
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to PACS in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PACS in the last 3 months.
Highest
Current $35.07
$52.00 (+48.27%)
Average
$49.20 (+40.29%)
Lowest
$44.00 (+25.46%)
News stories
From sources across the web
About PACS Group Inc
CEO-
Employees47.5K
Founded2013
HeadquartersSalt Lake City, Utah, United States
SectorHealth care provider
Websitepacs.com
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.64 / $0.41
+56.80%beat
Revenue / Est. (USD)
1.42B / 1.36B
+4.12%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.31B
1.34B
1.36B
1.42B
Cost of goods sold
1.11B
1.13B
1.12B
1.16B
Cost of revenue
1.11B
1.13B
1.12B
1.16B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110.00M
112.44M
123.29M
122.45M
Operating expense
123.17M
126.84M
138.67M
140.52M
Total operating expenses
1.23B
1.26B
1.26B
1.30B
Operating income
80.50M
86.27M
94.69M
120.04M
Other non operating income
2.48M
-956.00K
-99.00K
-330.00K
EBT including unusual items
78.61M
76.30M
86.81M
113.74M
EBT excluding unusual items
78.61M
76.30M
86.81M
113.74M
Income tax expense
27.65M
23.97M
27.03M
33.07M
Effective tax rate
35.17%
31.41%
31.13%
29.07%
Other operating expenses
-
-
-
-
Net income
50.96M
52.41M
59.70M
80.70M
Net profit margin
3.89%
3.90%
4.40%
5.68%
Earnings per share
0.46
0.45
0.57
0.64
Interest and investment income
-
-
-
-
Interest expense
-4.35M
-8.53M
-8.58M
-6.42M
Net interest expenses
-4.35M
-8.53M
-8.58M
-6.42M
Depreciation and amortization charges
13.18M
14.40M
15.38M
18.08M
EBITDA
93.68M
100.67M
110.07M
138.11M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer